Find Paid Clinical Trials in Wisconsin

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Wisconsin

Top of Directory » All Locations » United States » Wisconsin




  • A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne

    Condition:   Acne Vulgaris
    Interventions:   Drug: Tazarotene foam;   Drug: Vehicle Foam
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

    Condition:   Onychomycosis
    Interventions:   Drug: Albaconozole;   Drug: Placebo;   Drug: Albaconozole;   Drug: Placebo;   Drug: Albaconozole;   Drug: Placebo
    Sponsor:   Stiefel, a GSK Company
    Recruiting - verified November 2009

  • Evaluating an Interactive Cancer Communication System (ICCS) in Lung Cancer

    Condition:   Lung Cancer, Stage IIIb or IV
    Intervention:   Other: CHESS website for lung cancer patient + internet access if needed
    Sponsors:   University of Wisconsin, Madison;   Harry Gray Cancer Center Hartford Hospial;   M.D. Anderson Cancer Center;   University of Illinois;   University of Wisconsin Carbone Cancer Center
    Not yet recruiting - verified November 2009

  • A Study of Tocilizumab as Monotherapy and in Combination With Methotrexate Versus Methotrexate in Patients With Early Moderate to Severe Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis

    Condition:   Onychomycosis
    Interventions:   Drug: IDP-108;   Drug: Vehicle
    Sponsor:   Dow Pharmaceutical Sciences
    Not yet recruiting - verified November 2009

  • Study of A3309 in Patients With Chronic Idiopathic Constipation

    Conditions:   Constipation;   Chronic Constipation
    Intervention:   Drug: A3309
    Sponsor:   Albireo
    Recruiting - verified November 2009

  • Trial of LBH589 in Metastatic Thyroid Cancer

    Condition:   Thyroid Carcinoma
    Intervention:   Drug: LBH589
    Sponsors:   University of Wisconsin, Madison;   Novartis Pharmaceuticals
    Not yet recruiting - verified November 2009

  • Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer

    Condition:   Carcinoma, Non Small Cell Lung
    Interventions:   Drug: ZD6474 (vandetanib);   Drug: Faslodex (Fulvestrant)
    Sponsors:   University of Wisconsin, Madison;   AstraZeneca;   University of Pittsburgh
    Not yet recruiting - verified October 2009

  • Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma

    Conditions:   Lymphoma;   Lymphoproliferative Disorder
    Interventions:   Other: biologic sample preservation procedure;   Other: informational intervention
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms

    Condition:   Major Depressive Disorder
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Not yet recruiting - verified November 2009

  • Behavioral Trial Studying Programmed Training to Improve Advocacy Skills for Individuals With Traumatic Brain Injury

    Condition:   Brain Injuries
    Interventions:   Behavioral: Advocacy training curriculum;   Behavioral: Self-directed
    Sponsor:   Mayo Clinic
    Recruiting - verified October 2009

  • Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

    Conditions:   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
    Interventions:   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI);   Eastern Cooperative Oncology Group
    Recruiting - verified November 2009

  • TAXUS Libertē Post Approval Study

    Condition:   Coronary Artery Disease
    Interventions:   Device: TAXUS Liberté Paclitaxel-Eluting Coronary Stent;   Drug: prasugrel;   Drug: placebo;   Drug: aspirin
    Sponsors:   Boston Scientific Corporation;   Eli Lilly and Company;   Daiichi Sankyo Inc.
    Not yet recruiting - verified November 2009

  • The Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis to Assess the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: Placebo;   Biological: Certolizumab pegol
    Sponsor:   UCB, Inc.
    Recruiting - verified November 2009

  • Long Term Safety and Efficacy Trial of Budesonide Dipropionate - Hydroflouroalkane (BDP-HFA) 320 Mcg in Allergic Rhinitis

    Condition:   Rhinitis, Allergic, Perennial
    Interventions:   Drug: BDP;   Drug: Placebo
    Sponsor:   Teva Global Respiratory Research LLC
    Recruiting - verified October 2009

  • Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

    Condition:   Lung Cancer
    Interventions:   Biological: cetuximab;   Biological: cixutumumab;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Eastern Cooperative Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

    Conditions:   Brain and Central Nervous System Tumors;   Neurotoxicity
    Interventions:   Drug: temozolomide;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
    Sponsors:   Eastern Cooperative Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study in Adolescents With Schizophrenia or Bipolar Disorder

    Conditions:   Bipolar I Disorder;   Schizophrenia
    Interventions:   Drug: Olanzapine;   Behavioral: Standard behavioral weight intervention;   Behavioral: Intense behavioral weight intervention
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

    Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Dapagliflozin;   Drug: Placebo;   Drug: Hydrochlorothiazide
    Sponsors:   Bristol-Myers Squibb;   AstraZeneca
    Recruiting - verified November 2009

  • A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

    Condition:   Parkinson's Disease
    Interventions:   Drug: IPX066;   Drug: regular carbidopa-levodopa
    Sponsor:   IMPAX Laboratories, Inc.
    Recruiting - verified November 2009

  • Efficacy and Safety Study of NBI-56418 Na in Subjects With Endometriosis

    Conditions:   Endometriosis;   Pain
    Interventions:   Drug: NBI-56418;   Drug: Placebo
    Sponsor:   Neurocrine Biosciences
    Recruiting - verified November 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Placebo;   Drug: Dutogliptin
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified November 2009

  • CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride

    Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: JNJ-28431754;   Drug: glimepiride
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • A Study in Patients With Rheumatoid Arthritis

    Condition:   Rheumatoid Arthritis
    Interventions:   Biological: LY2439821;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study for Adult Patients With Fibromyalgia

    Conditions:   Fibromyalgia, Primary;   Fibromyalgia, Secondary
    Interventions:   Drug: Duloxetine;   Drug: Placebo
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)

    Conditions:   Pain;   Neuralgia, Postherpetic;   Neuralgia;   Mononeuropathies
    Interventions:   Drug: Placebo;   Drug: JNJ-42160443
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Study of Blood Samples From Newborns With Down Syndrome

    Condition:   Leukemia
    Interventions:   Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: cytogenetic analysis;   Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: flow cytometry;   Other: laboratory biomarker analysis;   Other: pharmacological study
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • A Study in Relapse Prevention of Treatment-resistant Depression

    Condition:   Treatment Resistant Depression
    Interventions:   Drug: Olanzapine and Fluoxetine combination;   Drug: Fluoxetine
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • A Study of the Antiviral Activity, Safety, and Tolerability of Intravenous Peramivir in Adult and Adolescent Hospitalized Subjects With Confirmed or Suspected Influenza Infection

    Conditions:   Seasonal Influenza;   Cough;   Sore Throat;   Nasal Congestion;   Myalgia;   Headache;   Feverishness;   Fatigue
    Interventions:   Drug: Peramivir;   Drug: Peramivir
    Sponsors:   BioCryst Pharmaceuticals;   Department of Health and Human Services
    Recruiting - verified November 2009

  • Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy

    Conditions:   Breast Cancer;   Hot Flashes;   Menopausal Symptoms;   Unspecified Adult Solid Tumor, Protocol Specific
    Interventions:   Dietary Supplement: flaxseed;   Other: placebo
    Sponsors:   North Central Cancer Treatment Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine Carcinosarcoma

    Condition:   Sarcoma
    Interventions:   Drug: carboplatin;   Drug: ifosfamide;   Drug: paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of VX-770 in Cystic Fibrosis Subjects Age 12 and Older Homozygous for the F508del-CFTR Mutation

    Condition:   Cystic Fibrosis
    Interventions:   Drug: VX-770;   Drug: Placebo
    Sponsors:   Vertex Pharmaceuticals Incorporated;   Cystic Fibrosis Foundation
    Recruiting - verified November 2009

  • COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial

    Condition:   Myelofibrosis
    Interventions:   Drug: INCB018424;   Drug: Placebo
    Sponsor:   Incyte Corporation
    Recruiting - verified November 2009

  • Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery

    Condition:   Kidney Stones
    Interventions:   Device: Cyberwand;   Device: Stonebreaker;   Device: Lithoclast Select
    Sponsor:   Indiana Kidney Stone Institute
    Recruiting - verified November 2009

  • Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II or Stage III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Conditions:   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
    Interventions:   Biological: bevacizumab;   Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

    Condition:   Lung Cancer
    Interventions:   Biological: bevacizumab;   Biological: cetuximab;   Drug: carboplatin;   Drug: paclitaxel
    Sponsors:   Southwest Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children 6-17 Years of Age With Urea Cycle Disorders, With a Long-Term Safety Extension

    Condition:   Urea Cycle Disorders
    Intervention:   Drug: HPN-100
    Sponsor:   Hyperion Therapeutics, Inc.
    Recruiting - verified October 2009

  • Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Glimepiride With or Without Metformin

    Condition:   Diabetes Mellitus, Type II
    Interventions:   Drug: Dutogliptin;   Drug: Placebo
    Sponsors:   Forest Laboratories;   Phenomix
    Recruiting - verified October 2009

  • A Study of the Safety and Efficacy of JNJ-39758979 in the Treatment of Adults With Asthma

    Condition:   Asthma
    Intervention:   Drug: JNJ39758979
    Sponsor:   Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    Recruiting - verified November 2009

  • Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor

    Conditions:   Kidney Cancer;   Precancerous/Nonmalignant Condition
    Interventions:   Biological: dactinomycin;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide phosphate;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: neoadjuvant therapy;   Procedure: therapeutic conventional surgery
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage III or Stage IVA Endometrial Cancer

    Condition:   Endometrial Cancer
    Interventions:   Drug: carboplatin;   Drug: cisplatin;   Drug: paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer

    Conditions:   Bladder Cancer;   Prostate Cancer;   Transitional Cell Cancer of the Renal Pelvis and Ureter;   Urethral Cancer
    Interventions:   Biological: bevacizumab;   Drug: cisplatin;   Drug: gemcitabine hydrochloride;   Drug: placebo administration
    Sponsors:   Cancer and Leukemia Group B;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

    Condition:   Asthma
    Interventions:   Drug: QMF149 Twisthaler®;   Drug: Mometasone Twisthaler®
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified November 2009

  • A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Conditions:   Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cavity Cancer
    Interventions:   Biological: A6;   Other: laboratory biomarker analysis
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease

    Condition:   Alzheimer's Disease
    Intervention:   Drug: Dimebon
    Sponsors:   Pfizer;   Medivation, Inc.
    Recruiting - verified November 2009

  • Vorinostat and Bortezomib in Treating Patients With Advanced Soft Tissue Sarcoma

    Condition:   Sarcoma
    Interventions:   Drug: bortezomib;   Drug: vorinostat
    Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
    Recruiting - verified October 2009

  • A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

    Condition:   Postmenopausal Osteoporosis
    Interventions:   Drug: Ibandronate;   Drug: Denosumab
    Sponsor:   Amgen
    Not yet recruiting - verified November 2009

  • Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

    Condition:   Prostate Cancer
    Interventions:   Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin;   Drug: leuprolide acetate;   Drug: triptorelin;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy
    Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
    Recruiting - verified November 2009

  • Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

    Condition:   Degenerative Disc Disease
    Intervention:   Device: NUBAC™
    Sponsor:   Pioneer Surgical Technology, Inc.
    Recruiting - verified November 2009

    • Menu
    Find Paid Clinical Trials